Evaluation of efficacy and safety of Aujeszky's disease vaccines.
Since Aujeszky's disease have become an economic problem in pig farms in late 1960's and early 1970's many different vaccines, either inactivated or live - attenuated were developed. Soon it became evident that they differ in their efficacy. In this article a panel of tests used for evaluation of safety and efficacy of inactivated as well as live Aujeszky's disease vaccines is described.
Lipowski
A
A
Department of Swine Diseases, National Veterinary Research Institute, Partyzantów 57, 24-100 Puławy, Poland. lipowski@piwet.pulawy.pl
D000818:Animals; D011558:Herpesvirus 1, Suid / Q000276:immunology*; D011557:Pseudorabies / Q000517:prevention & control*; D022421:Pseudorabies Vaccines / Q000276:immunology*; D012449:Safety; D013552:Swine; D013553:Swine Diseases / Q000517:prevention & control*; D016896:Treatment Outcome; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic
D022421:Pseudorabies Vaccines; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic